Holen Sie sich die Stockscreener-App
4.87
3.84%
0.18
Schlusskurs vom Vortag:
$4.69
Offen:
$4.86
24-Stunden-Volumen:
116.13K
Relative Volume:
0.01
Marktkapitalisierung:
$15.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.75M
KGV:
-1.4985
EPS:
-3.25
Netto-Cashflow:
$-30.91M
1W Leistung:
-0.20%
1M Leistung:
+3.40%
6M Leistung:
+1,594%
1J Leistung:
+122.37%
1-Tages-Spanne:
$4.43
$4.97
1-Wochen-Bereich:
$4.43
$5.2953
52-Wochen-Spanne:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Firmenname
Cellectar Biosciences Inc
Sektor
Branche
Telefon
(608) 441-8120
Adresse
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Vergleichen Sie CLRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.87 | 14.97M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2020-07-01 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-21 | Fortgesetzt | ROTH Capital | Buy |
| 2019-09-13 | Eingeleitet | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
How to use a screener to detect Cellectar Biosciences Inc. breakoutsQuarterly Profit Report & Free Safe Capital Growth Stock Tips - Newser
Real time social sentiment graph for Cellectar Biosciences Inc.Chart Signals & Reliable Entry Point Alerts - Newser
What’s the recovery path for long term holders of Cellectar Biosciences Inc.Market Risk Analysis & Daily Profit Focused Screening - Newser
What’s next for Cellectar Biosciences Inc. stock priceM&A Rumor & AI Forecasted Stock Moves - Newser
Analyzing drawdowns of Cellectar Biosciences Inc. with statistical toolsMarket Performance Recap & Advanced Technical Signal Analysis - Newser
Is it time to cut losses on Cellectar Biosciences Inc.Portfolio Performance Summary & Short-Term High Return Ideas - Newser
Published on: 2025-08-29 15:00:03 - Newser
Visualizing Cellectar Biosciences Inc. stock with heatmapsTrade Ideas & Long-Term Investment Growth Plans - Newser
Cellectar Biosciences Inc. stock momentum explainedShare Buyback & AI Powered Market Entry Strategies - Newser
Using Ichimoku Cloud for Cellectar Biosciences Inc. technicalsWeekly Investment Report & Growth Focused Stock Reports - Newser
Technical analysis overview for Cellectar Biosciences Inc. stockEarnings Performance Report & AI Driven Stock Movement Reports - Newser
Is Cellectar Biosciences Inc. trending in predictive chart modelsQuarterly Profit Review & Weekly High Potential Stock Alerts - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.July 2025 Intraday Action & Long-Term Safe Investment Plans - Newser
Does Cellectar Biosciences Inc. show high probability of reboundBear Alert & AI Powered Buy and Sell Recommendations - Newser
How moving averages guide Cellectar Biosciences Inc. tradingQuarterly Investment Review & Real-Time Volume Spike Alerts - Newser
How to manage a losing position in Cellectar Biosciences Inc.2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Key metrics from Cellectar Biosciences Inc.’s quarterly data2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
How sentiment analysis helps forecast Cellectar Biosciences Inc.Recession Risk & Real-Time Stock Price Movement Reports - Newser
Institutional scanner results for Cellectar Biosciences Inc.Weekly Volume Report & High Conviction Buy Zone Picks - Newser
Cellectar Biosciences Inc. stock trend forecastWeekly Profit Report & Safe Entry Point Identification - Newser
Short interest data insights for Cellectar Biosciences Inc.Options Play & Advanced Swing Trade Entry Plans - Newser
How to recover losses in Cellectar Biosciences Inc. stockJuly 2025 Highlights & Community Supported Trade Ideas - Newser
Cellectar Biosciences Inc. stock chart pattern explainedIPO Watch & Risk Controlled Swing Alerts - Newser
Cellectar Biosciences shares rise 3.74% intraday after announcing oral presentation at AACR Special Conference on Pediatric Cancer. - AInvest
Cellectar Cuts Q2 Losses and Expenses - AOL.com
Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer - The Manila Times
Cellectar Biosciences Announces AACR Oral Presentation for Pediatric Cancer Treatment - AInvest
Cellectar Biosciences to Present Data in Oral Session and - GlobeNewswire
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cellectar Biosciences Inc-Aktie (CLRB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):